Paragon Capital Management Upped Its Pfizer (PFE) Position; National Grid plc (NGG) Had 2 Bulls

Pfizer Inc. (NYSE:PFE) Logo

Among 2 analysts covering National Grid (NYSE:NGG), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. National Grid had 2 analyst reports since January 30, 2019 according to SRatingsIntel. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, February 6. See National Grid plc (NYSE:NGG) latest ratings:

06/02/2019 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Outperform Upgrade
30/01/2019 Broker: Barclays Capital Rating: Overweight Initiates Coverage On

Paragon Capital Management Llc increased Pfizer Incorporated (PFE) stake by 118.96% reported in 2018Q3 SEC filing. Paragon Capital Management Llc acquired 3,803 shares as Pfizer Incorporated (PFE)’s stock rose 5.56%. The Paragon Capital Management Llc holds 7,000 shares with $308.00M value, up from 3,197 last quarter. Pfizer Incorporated now has $239.49 billion valuation. The stock decreased 1.05% or $0.44 during the last trading session, reaching $41.43. About 9.09 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 13, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 15/05/2018 – U.S. FDA – APPROVED RETACRIT AS BIOSIMILAR TO EPOGEN/PROCRIT FOR TREATMENT OF ANEMIA; 01/05/2018 – PFIZER ENDS FIRST QUARTER EARNINGS CALL; 29/05/2018 – Roche: Study is on Tecentriq Plus Chemotherapy for Type of Lung Cancer; 01/05/2018 – Pfizer Remaining Share-Repurchase Authorization $10.3B; 23/04/2018 – Pfizer Provides Update on Proposed Trastuzumab Biosimilar; 20/03/2018 – Roche’s Tecentriq with Chemotherapy Phase III IMpower131 Study Met Co-Primary Endpoint; 16/05/2018 – PHASE lll IMPOWER150 STUDY SHOWED GENENTECH’S TECENTRIQ AND AVASTIN PLUS CARBOPLATIN AND PACLITAXEL HELPED PEOPLE WITH A SPECIFIC TYPE OF METASTATIC LUNG CANCER LIVE SIGNIFICANTLY LONGER COMPARED TO; 03/04/2018 – Pfizer signs deal with Allogene to develop cancer cell therapy; 07/05/2018 – PFIZER INDIA QTR NET 1.05B RUPEES; 19/03/2018 – PFIZER SAYS FDA GRANTS PRIORITY REVIEW FOR SNDA FOR XTANDI

National Grid plc transmits and distributes electricity and natural gas. The company has market cap of $37.34 billion. It operates through UK Electricity Transmission, UK Gas Transmission, and US Regulated divisions. It has a 8.44 P/E ratio. The UK Electricity Transmission segment owns and operates electricity transmission networks, which comprise approximately 7,200 kilometers of overhead line; 1,500 kilometers of underground cable; and 342 substations located in England and Wales.

The stock decreased 0.22% or $0.12 during the last trading session, reaching $54.38. About 159,652 shares traded. National Grid plc (NYSE:NGG) has declined 13.47% since February 13, 2018 and is downtrending. It has underperformed by 13.47% the S&P500. Some Historical NGG News: 01/05/2018 – National Grid: Sale Will Allow Rebalance to a Portfolio That Delivers Asset Growth of 5%-7%; 17/05/2018 – NATIONAL GRID PLC – OVERALL GROUP CAPITAL INVESTMENT FOR 2018/19 IS EXPECTED TO BE AT A SIMILAR LEVEL TO £4.3 BLN OF INVESTMENT IN 2017/18; 22/05/2018 – Ofgem to Probe National Grid Electricity Transmission’s Forecasting; 13/03/2018 – New York loses appeal to block Millennium natgas pipeline; 04/05/2018 – National Grid PLC CFO Andrew Bonfield to Leave; 10/04/2018 – National Grid forecasts low electricity demand in Britain this summer; 04/05/2018 – National Grid: Mr Bonfield to Step Down July 30; 14/03/2018 – NATIONAL GRID PLC NG.L : UBS RAISES TO NEUTRAL FROM SELL; 31/05/2018 – NATIONAL GRID PLC NG.L : JP MORGAN RAISES TARGET PRICE TO 950P FROM 870P; 11/05/2018 – NATIONAL GRID PLC NG.L : HSBC RAISES TARGET PRICE TO 930P FROM 900P

More notable recent National Grid plc (NYSE:NGG) news were published by: Seekingalpha.com which released: “Bert’s January Dividend Income Summary – Seeking Alpha” on February 09, 2019, also Nasdaq.com with their article: “Mid-Morning Market Update: Markets Open Lower; Twitter Shares Drop After Light Forecast – Nasdaq” published on February 07, 2019, Gurufocus.com published: “6 Low Price-Sales Stocks – GuruFocus.com” on January 30, 2019. More interesting news about National Grid plc (NYSE:NGG) were released by: Investorplace.com and their article: “10 of the Best Stocks to Invest In for February – Investorplace.com” published on January 24, 2019 as well as Benzinga.com‘s news article titled: “Benzinga’s Top Upgrades, Downgrades For January 30, 2019 – Benzinga” with publication date: January 30, 2019.

Since January 30, 2019, it had 0 insider purchases, and 1 sale for $1.81 million activity. LANKLER DOUGLAS M sold $1.81M worth of Pfizer Inc. (NYSE:PFE) on Wednesday, January 30.

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Barometer stated it has 1.17% in Pfizer Inc. (NYSE:PFE). Savings Bank Of Stockton holds 0.16% of its portfolio in Pfizer Inc. (NYSE:PFE) for 7,034 shares. Peloton Wealth Strategists reported 50,900 shares stake. State Of Alaska Department Of Revenue has 1.05% invested in Pfizer Inc. (NYSE:PFE). Cap City Co Fl reported 4,809 shares. Pettyjohn Wood White invested 1.12% in Pfizer Inc. (NYSE:PFE). Perkins Capital Management has 67,569 shares for 1.79% of their portfolio. California-based Kelly Lawrence W And Associate Ca has invested 0.15% in Pfizer Inc. (NYSE:PFE). Private Ocean Limited invested 0% of its portfolio in Pfizer Inc. (NYSE:PFE). Rothschild Inv Il invested in 239,982 shares. Davenport & Co Ltd Liability Com invested 0.15% in Pfizer Inc. (NYSE:PFE). Horrell Incorporated stated it has 159 shares. Manufacturers Life Insurance Co The holds 8.74M shares or 0.41% of its portfolio. Wade G W And reported 0.27% in Pfizer Inc. (NYSE:PFE). Caprock Grp Inc Inc stated it has 71,338 shares.

Paragon Capital Management Llc decreased Nextera Energy Inc (NYSE:NEE) stake by 179,330 shares to 3,300 valued at $553.00 million in 2018Q3. It also reduced Conocophillips (NYSE:COP) stake by 33,167 shares and now owns 98,381 shares. Zions Bancorp (NASDAQ:ZION) was reduced too.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “Pfizer Inc. (NYSE: PFE) and Astellas Announce Phase 3 ARCHES Trial Shows XTANDI Significantly Improved Radiographic PFS in Men with Metastatic Hormone-Sensitive Prostate Cancer – StreetInsider.com” on February 11, 2019, also Seekingalpha.com with their article: “Pfizer: Strong Buy Heading Into 2019 – Seeking Alpha” published on January 30, 2019, Seekingalpha.com published: “Pfizer Q4 2018 Earnings Preview – Seeking Alpha” on January 28, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer Biopharmaceuticals Group’s Late-Stage Pipeline Looks Well Positioned – Seeking Alpha” published on February 06, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer recalls contaminated high blood pressure drug in Japan – Seeking Alpha” with publication date: February 08, 2019.

Among 8 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 1 Sell and 4 Hold. Therefore 38% are positive. Pfizer had 9 analyst reports since August 23, 2018 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) has “Outperform” rating given on Thursday, January 31 by Credit Suisse. The firm has “Equal-Weight” rating given on Thursday, August 23 by Barclays Capital. The rating was upgraded by Argus Research on Thursday, January 31 to “Outperform”. UBS downgraded Pfizer Inc. (NYSE:PFE) on Wednesday, January 23 to “Neutral” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Market Perform” rating given on Thursday, November 1 by BMO Capital Markets. The firm has “Sell” rating by Citigroup given on Tuesday, November 6. On Thursday, August 23 the stock rating was maintained by Morgan Stanley with “Overweight”. The firm earned “Neutral” rating on Tuesday, December 11 by JP Morgan. The stock of Pfizer Inc. (NYSE:PFE) has “Neutral” rating given on Wednesday, October 31 by Credit Suisse.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart